search
Back to results

Cryolipolysis on Localized Adiposity

Primary Purpose

Subcutaneous Fat

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Cryolipolysis
Sponsored by
Federal University of Health Science of Porto Alegre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Subcutaneous Fat

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Female
  • Age 18 to 45 or not being on menopause
  • Sedentary according to International Physical Activity Questionnaire
  • Body Mass Index lower than 27 Kg/m²
  • Skinfold: more than 3 centimeters at the lower abdomen

Exclusion Criteria:

  • Cryoglobulinemia
  • Cold urticaria
  • Paroxysmal cold hemoglobinuria
  • Raynaud disease
  • Pregnancy and Breastfeeding
  • Cancer
  • Vascular diseases
  • Heart diseases
  • Epidermal lesions at the site of application
  • Autoimmune diseases
  • Osteoporosis
  • Metallic implants and pacemaker
  • Alterations of sensibility
  • Inflammatory process and active infection
  • Abdominal hernia
  • Abdominal muscle diastasis
  • Diabetes
  • Anemia
  • Previous plastic surgery on the area
  • Liver and kidney diseases
  • Cognitive impairment that prevents conducting evaluations, as well as inability to understand and sign the informed consent form

Sites / Locations

  • Federal University of Health Science of Porto Alegre

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Active Comparator

Arm Label

Control Group

Intervention Group

Arm Description

Subjects will only receive the Evaluation Protocol and will be followed for 90 days.

A single 50 minutes session of cold exposure with a cryolipolysis device. The parameters will be: temperature -10°C and vacuum between 60 Kpas (at beginning) and 40 Kpas (until the end).

Outcomes

Primary Outcome Measures

Subcutaneous fat layer
Subcutaneous fat layer changes measured by ultrasonography and skinfold.

Secondary Outcome Measures

Abdominal circumference
Abdominal circumference changes measured by perimetry method.
Inflammatory profile
Inflammatory profile analyzed through level of interleukin - 6, tumor necrosis factor - alfa, monocyte chemotactic protein-1 and leptin.
Body fat mass
Body fat mass changes measured by bioimpedance.
Liver function
Liver function analyzed through aspartate aminotransferase and alanine aminotransferase
Kidney function
Kidney function analyzed through creatinine and urea
Lipids profile
Lipids profile analyzed through high density lipoprotein, low density lipoprotein, cholesterol, triglycerides and glucose levels.
Local temperature
Local temperature changes with cryolipolysis measured by thermographic analysis.
Adverse effects
Identification of possible adverse effects by patient report
Pain level
Pain level measured by analogue visual pain scale
Body weight and body mass index
Body weight and body mass index
Physical Activity
Level of physical activity measured by the International Physical Activity Questionnaire

Full Information

First Posted
May 16, 2017
Last Updated
May 22, 2017
Sponsor
Federal University of Health Science of Porto Alegre
search

1. Study Identification

Unique Protocol Identification Number
NCT03160976
Brief Title
Cryolipolysis on Localized Adiposity
Official Title
Effects of Cryolipolysis on Localized Adiposity: Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Unknown status
Study Start Date
May 25, 2017 (Anticipated)
Primary Completion Date
August 25, 2017 (Anticipated)
Study Completion Date
October 25, 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Health Science of Porto Alegre

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of this study is to analyze the effects of a single session of cryolipolysis on localized adiposity on women's abdomen. This is a randomized controlled clinical trial that will include 28 women who will be randomly allocated into two groups: Control Group or Intervention Group. The following assessments will be performed in both groups: ultrasonography and body composition at baseline and 30, 60 and 90 days after randomization and blood analysis at baseline and 15 and 30 days after randomization. The expected main result at the end of this study is the reduction of the local subcutaneous fat tissue.
Detailed Description
Cryolipolysis is a non - invasive method for localized fat reduction wich uses low temperatures to induce an apoptotic and inflammatory response and consequent adipocyte death in the treated area. Although the practice of this technique has been increasing, there are some gaps in the literature about the exact mechanism of action and only a few randomized clinical trials that proves its effectiveness and safety. Then, the aim of this study is to analyse the effects of cryolipolysis on localized fat on women's abdomen. This is a randomized controlled clinical trial that will include 28 women who will be randomized to Control Group (CG) or Intervention Group (IG). The CG will perform the Evaluation Protocol with the following assessments: ultrasonography, thermographic analysis, blood analysis, bioimpedance and measurement of skinfold and abdominal circumference. The IG will receive a single cryolipolysis's session on lower abdomen and the Evaluation Protocol. The follow up for both groups is 90 days. Expected main result at the end of the study is the reduction of the local subcutaneous fat tissue.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Subcutaneous Fat

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
28 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Subjects will only receive the Evaluation Protocol and will be followed for 90 days.
Arm Title
Intervention Group
Arm Type
Active Comparator
Arm Description
A single 50 minutes session of cold exposure with a cryolipolysis device. The parameters will be: temperature -10°C and vacuum between 60 Kpas (at beginning) and 40 Kpas (until the end).
Intervention Type
Other
Intervention Name(s)
Cryolipolysis
Intervention Description
First, the demarcation of the lower abdomen area at the same landmarks of the ultrasonography will be done. Secondly, the patient will be positioned on the stretcher in the supine position with a 45 ° elevation of the trunk. In this position, to protect the region to be treated, a glycerine antifreeze membrane will be placed. The treatment parameters will be: temperature of -10 ° C, treatment time of 50 minutes (first 3 minutes of heating at 42°C) and moderate vacuum pressure (60 - 40 Kpas). The applicator will be chosen according to the size of the area of each subject and positioned in the target region. At the end the skinfold will be released automatically, the antifreeze membrane removed and a manual massage will be carried out for five minutes to stimulate local blood reperfusion.
Primary Outcome Measure Information:
Title
Subcutaneous fat layer
Description
Subcutaneous fat layer changes measured by ultrasonography and skinfold.
Time Frame
Baseline, 30, 60 and 90 days after intervention.
Secondary Outcome Measure Information:
Title
Abdominal circumference
Description
Abdominal circumference changes measured by perimetry method.
Time Frame
Baseline, 30, 60 and 90 days after intervention.
Title
Inflammatory profile
Description
Inflammatory profile analyzed through level of interleukin - 6, tumor necrosis factor - alfa, monocyte chemotactic protein-1 and leptin.
Time Frame
Baseline, 15 and 30 days after intervention.
Title
Body fat mass
Description
Body fat mass changes measured by bioimpedance.
Time Frame
Baseline, 30, 60 and 90 days after intervention.
Title
Liver function
Description
Liver function analyzed through aspartate aminotransferase and alanine aminotransferase
Time Frame
Baseline, 15 and 30 days after intervention.
Title
Kidney function
Description
Kidney function analyzed through creatinine and urea
Time Frame
Baseline, 15 and 30 days after intervention.
Title
Lipids profile
Description
Lipids profile analyzed through high density lipoprotein, low density lipoprotein, cholesterol, triglycerides and glucose levels.
Time Frame
Baseline, 15 and 30 days after intervention
Title
Local temperature
Description
Local temperature changes with cryolipolysis measured by thermographic analysis.
Time Frame
2 minutes before and 2 minutes after intervention and massage
Title
Adverse effects
Description
Identification of possible adverse effects by patient report
Time Frame
15 days after intervention
Title
Pain level
Description
Pain level measured by analogue visual pain scale
Time Frame
First minute, twenty-fifth minute, fiftieth minute after intervention and first minute during the massage
Title
Body weight and body mass index
Description
Body weight and body mass index
Time Frame
Baseline, 30, 60 and 90 days after intervention.
Title
Physical Activity
Description
Level of physical activity measured by the International Physical Activity Questionnaire
Time Frame
Baseline and every 15 days after intervention

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Female Age 18 to 45 or not being on menopause Sedentary according to International Physical Activity Questionnaire Body Mass Index lower than 27 Kg/m² Skinfold: more than 3 centimeters at the lower abdomen Exclusion Criteria: Cryoglobulinemia Cold urticaria Paroxysmal cold hemoglobinuria Raynaud disease Pregnancy and Breastfeeding Cancer Vascular diseases Heart diseases Epidermal lesions at the site of application Autoimmune diseases Osteoporosis Metallic implants and pacemaker Alterations of sensibility Inflammatory process and active infection Abdominal hernia Abdominal muscle diastasis Diabetes Anemia Previous plastic surgery on the area Liver and kidney diseases Cognitive impairment that prevents conducting evaluations, as well as inability to understand and sign the informed consent form
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Rodrigo DM Plentz, PhD
Phone
55 51 91131651
Email
roplentz@yahoo.com.br
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rodrigo DM Plentz, PhD
Organizational Affiliation
Federal University of Health Science of Porto Alegre
Official's Role
Principal Investigator
Facility Information:
Facility Name
Federal University of Health Science of Porto Alegre
City
Porto Alegre
State/Province
Rio Grande do Sul
ZIP/Postal Code
90050170
Country
Brazil
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rodrigo DM Plentz, PhD
Phone
55 51 998419044
Email
roplentz@yahoo.com.br

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31375459
Citation
Falster M, Schardong J, Santos DPD, Machado BC, Peres A, Rosa PVD, Plentz RDM. Effects of cryolipolysis on lower abdomen fat thickness of healthy women and patient satisfaction: a randomized controlled trial. Braz J Phys Ther. 2020 Sep-Oct;24(5):441-448. doi: 10.1016/j.bjpt.2019.07.005. Epub 2019 Jul 26.
Results Reference
derived

Learn more about this trial

Cryolipolysis on Localized Adiposity

We'll reach out to this number within 24 hrs